The US drug regulatory system fails to address the country’s most urgent medical needs with the resources appropriate for the task. But change is possible, say Christopher-Paul Milne and Kenneth I. Kaitin.
Christopher-Paul Milne, DVM, MPH, JD
Advertisement
Articles by Christopher-Paul Milne, DVM, MPH, JD
Advertisement
Latest Updated Articles
Meeting Unmet Medical Needs: The Disparity DilemmaPublished: February 3rd 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Merck Planning $70 Billion Investment for US Expansion
2
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
From Advantage to Essential: How Daily Data & AI Alerts Transform Commercial Functions
5
